Wednesday, July 8, 2026
🇺🇸 FDA

pharma · T Cell Lymphoma · Diabetes Mellitus · CRSP

S.A

S.A.

S.A patent portfolio — 65 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
San Lorenzo, EU HQ
2011 Founded
50 Employees
Public company Type
CRSP · NYSE Ticker
Company details
Status
Public
HQ
San Lorenzo, EU
Founded
2011
Employees
50
Programs
14
Drugs
8
Patents
65
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

S.A patents

65 pharmaceutical patents indexed for S.A. 0 expire within 24 months.

S.A has 65 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

65 patents

Patent portfolio

Page 1 of 2

  1. US 12427170

    Universal donor cells

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12344655

    Gene-edited natural killer cells

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12344656

    Genetically engineered T cells having improved persistence in culture

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12304968

    T-cells expressing anti-LIV1 chimeric antigen receptor

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12263227

    Optimized mRNA encoding CAS9 for use in LNPs

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12247201

    Materials and methods for treatment of autosomal dominant retinitis pigmentosa

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12241087

    Compositions and methods for differentiating stem cells into NK cells

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12227763

    Methods and compositions for treating cancer

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12215316

    Materials and methods for treatment of usher syndrome type 2A

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12215320

    Compositions and methods for gene editing by targeting transferrin

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12188060

    Messenger RNA encoding Cas9 for use in genome-editing systems

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12186406

    Materials and methods for treatment of hereditary haemochromatosis

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12122998

    Materials and methods for treatment of usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12037616

    Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditions

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12016932

    Gene editing for hemophilia A with improved factor VIII expression

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11958908

    Compositions and methods for the depletion of CD117+ cells

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11926676

    Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11866727

    Materials and methods for treatment of glycogen storage disease type 1A

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11857574

    Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11851653

    Materials and methods for treatment of alpha-1 antitrypsin deficiency

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11833225

    Methods and compositions for efficient gene deletion

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11827877

    Compositions and methods for genomic editing by insertion of donor polynucleotides

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11679131

    Genetically engineered T cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11679130

    Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11649438

    Methods and compositions for treating cancer

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11622977

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11591381

    Gene-edited natural killer cells

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11578309

    Universal donor cells

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11566230

    Universal donor cells

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11564997

    Materials and methods for treatment of friedreich ataxia and other related disorders

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11559588

    Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11529427

    Gene editing for hemophilia A with improved factor VIII expression

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11497773

    Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11471491

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11473060

    Compositions and methods for differentiating stem cells into NK cells

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11459372

    Gene-edited natural killer cells

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11434505

    Universal donor cells

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11433103

    Universal donor cells

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11407997

    Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11389481

    Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11332760

    Compositions and methods for genomic editing by insertion of donor polynucleotides

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11298378

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11254912

    Methods and compositions for treating cancer

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11207351

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11202802

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11191783

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11174469

    Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11166985

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does S.A have?

65 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do S.A patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.